Effects of pulsed magnetic field on insulin-like growth factor-1 (IGF-1) in cerebrospinal fluid and effects of IGF-1 on functional recovery.
- Author:
Cheng-xian SONG
1
;
Jian-zhong FAN
;
Hong-ying WU
;
Yi WEI
;
Jian-rong ZHEN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Brain Injuries; cerebrospinal fluid; rehabilitation; therapy; Female; Humans; Insulin-Like Growth Factor I; cerebrospinal fluid; Magnetic Fields; Male; Middle Aged; Recovery of Function
- From: Journal of Southern Medical University 2010;30(10):2288-2294
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the effects of pulsed magnetic field on insulin-like growth factor-1 (IGF-1) level in the cerebrospinal fluid (CSF) and the association of IGF-1 alterations with the activities of daily living (ADL) of patients with brain injury.
METHODSSixty-five patients with brain injury were divided randomly into the control group (n=30) and magnetic therapy group (n=35), both receiving conventional therapy and in the latter group, daily pulsed magnetic field treatment (20-40 mT, 50 Hz, 20 min per time, 1 time per day) for 14 consecutive days were administered. On the first and 14th days of the treatment, 2 ml CSF was collected from the cases patients for IGF-1 measurement by radioimmunoassay, and Barthel index (BI) was used to assess the ADL of the patients.
RESULTSAfter a 14-day treatment, IGF-1 level in the CSF were significantly increased in the magnetic group in comparison with the level before the treatment and with those in the control group (P<0.05). IGF-1 in the CSF underwent no significant changes in the control group (P>0.05). The scores of BI increased significantly in both groups after the treatment (P<0.01), but the increment was more obvious in the magnetic therapy group (P<0.05). A significant positive correlation was found between IGF-1 level in the CSF and BI in these patients (r=0.283, P=0.022).
CONCLUSIONPulsed magnetic field might increase IGF-1 level in the CSF of patients with brain injury to promote the recovery of the patients ADL, suggesting its potential clinical value in the treatment of brain injury.